Imatinib mesylate induces hypophosphatemia in patients with...

Imatinib mesylate induces hypophosphatemia in patients with chronic myeloid leukemia in late chronic phase, and this effect is associated with response

S. Osorio, A. García Noblejas, A. Durán, J.L. Steegmann
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
82
Year:
2007
Language:
english
Pages:
2
DOI:
10.1002/ajh.20778
File:
PDF, 73 KB
english, 2007
Conversion to is in progress
Conversion to is failed